{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:57:54Z","timestamp":1768010274333,"version":"3.49.0"},"reference-count":16,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,1,30]]},"DOI":"10.1536\/ihj.20-437","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T22:08:17Z","timestamp":1610748497000},"page":"112-118","source":"Crossref","is-referenced-by-count":4,"title":["Risk Stratification of Percutaneous Edge-to-Edge Repair by MitraClip in Patients with Mitral Regurgitation"],"prefix":"10.1536","volume":"62","author":[{"given":"Shuhei","family":"Tanaka","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Ushijima","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005-11.","DOI":"10.1016\/S0140-6736(06)69208-8"},{"key":"2","unstructured":"2. Mirabel M, Iung B, Baron G, <i>et al<\/i>. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007; 28: 1358-65."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ponikowski P, Voors AA, Anker SD, <i>et al<\/i>. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-200.","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Baumgartner H, Falk V, Bax JJ, <i>et al<\/i>. 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38: 2739-91.","DOI":"10.1093\/eurheartj\/ehx391"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Stone GW, Lindenfeld J, Abraham WT, <i>et al<\/i>. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med 2018; 379: 2307-28.","DOI":"10.1056\/NEJMoa1806640"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Obadia JF, Messika-Zeitoun D, Leurent G, <i>et al<\/i>. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation. N Engl J Med 2018; 379: 2297-306.","DOI":"10.1056\/NEJMoa1805374"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pibarot P, Delgado V, Bax JJ. MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results. Eur Heart J Cardiovasc Imaginig 2019; 20: 620-44.","DOI":"10.1093\/ehjci\/jez073"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Solomon SD, Vaduganathan M, L Claggett B, <i>et al<\/i>. Sacubitril\/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure. Circulation 2020; 141: 352-61.","DOI":"10.1161\/CIRCULATIONAHA.119.044586"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Koelling TM, Aaronson KD, Cody RJ, Bath DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002; 144: 524-9.","DOI":"10.1067\/mhj.2002.123575"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Trichon BH, Felker GM, Shaw LK, Cabell CH, O&apos;Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003; 91: 538-43.","DOI":"10.1016\/S0002-9149(02)03301-5"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001; 103: 1759-64.","DOI":"10.1161\/01.CIR.103.13.1759"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kjaergaard J, Akkan D, Iversen KK, <i>et al<\/i>. Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol 2007; 99: 1146-50.","DOI":"10.1016\/j.amjcard.2006.11.052"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ghio S, Gavazzi A, Campana C, <i>et al<\/i>. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001; 37: 183-8.","DOI":"10.1016\/S0735-1097(00)01102-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Goodwin M, Nemeh HW, Borgi J, Paone G, Morgan JA. Resolution of Mitral Regurgitation With Left Ventricular Assist Device Support. Ann Thorac Surg 2017; 104: 811-8.","DOI":"10.1016\/j.athoracsur.2017.02.016"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Estep JD, Starling RC, Horstmanshof DA, <i>et al<\/i>. Risk assessment and comparative effectiveness of left ventricular assisst device and medical management in ambulatory heart failure patients. J Am Coll Cardiol 2015; 66: 1747-61.","DOI":"10.1016\/j.jacc.2015.07.075"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pagani FD, Aaronson KD, Kormos R, <i>et al<\/i>. The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assisst device therapy. J Heart Lung Transplant 2016; 35: 1277-83.","DOI":"10.1016\/j.healun.2016.09.002"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-437\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T03:54:46Z","timestamp":1611978886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-437\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-437","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]}}}